文献速递产科母胎医学

子痫前期外部验证预测模型:系统综述与Meta分析

Externally validated prediction models for pre-eclampsia: systematic review and meta-analysis.
PubMed 文献 · Ultrasound Obstet Gynecol · 2024-01-01

该系统综述与Meta分析评估了现有子痫前期外部验证预测模型的性能。检索5个数据库至2023年5月20日,纳入23项研究、52个外部验证模型。FMF早产子痫前期三联试验模型合并AUC为0.90(95%PI 0.76-0.96)且校准良好,其他模型区分度中位AUC为0.66(范围0.53-0.77)。

要点

  • FMF早产子痫前期三联试验模型在16个不同场景中广泛验证,合并AUC为0.90(95%PI 0.76-0.96)。
  • 其他模型区分度中位AUC为0.66(范围0.53-0.77),外部验证时普遍过拟合。
  • 除FMF模型外,仅两个基于母体特征的任意型子痫前期模型多次验证,合并AUC分别为0.71和0.73。

核心结论

  • 现有任意型、早发型和晚发型子痫前期外部验证预测模型的区分度和校准性能有限,且输入变量不一致。
  • 三联试验FMF模型在多个场景中预测早产子痫前期具有出色区分度,但包含特殊生物标志物可能限制其在高资源地区之外的可行性和实施。

研究设计与样本

  • 系统综述与Meta分析,系统检索MEDLINE、EMBASE、Emcare、CINHL和Maternity & Infant Care Database五个数据库及Google Scholar/参考文献检索,截至2023年5月20日。
  • 采用PICOTS方法识别研究,CHARMS清单提取数据,PROBAST工具评估偏倚风险。
  • 纳入23项研究,报告52个外部验证的子痫前期预测模型(1个早产、20个任意型、17个早发型、14个晚发型模型)。

主要发现

  • 15个任意型子痫前期模型各被外部验证1次,2个被验证2次,3个被验证3次;FMF早产子痫前期竞争风险模型在16个不同场景中广泛验证。
  • 最常见预测因子为母体特征(孕前体重指数、既往子痫前期、子痫前期家族史、慢性疾病和 ethnicity)和生物标志物(子宫动脉搏动指数和妊娠相关血浆蛋白-A)。
  • FMF早产子痫前期模型(三联试验加母体因素)性能最佳,合并AUC为0.90(95%PI 0.76-0.96),且校准良好。
  • 其他模型区分度普遍为差至好(中位AUC 0.66,范围0.53-0.77),外部验证时过拟合。
  • 除FMF模型外,仅两个多次验证的任意型子痫前期模型(仅基于母体特征)产生合理的合并AUC,分别为0.71(95%PI 0.66-0.76)和0.73(95%PI 0.55-0.86)。

关键数值与推荐

  • FMF早产子痫前期模型(三联试验加母体因素)合并AUC为0.90(95%PI 0.76-0.96),校准良好。
  • 其他模型区分度中位AUC为0.66(范围0.53-0.77)。
  • 两个仅基于母体特征的任意型子痫前期模型合并AUC分别为0.71(95%PI 0.66-0.76)和0.73(95%PI 0.55-0.86)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This systematic review and meta-analysis aimed to evaluate the performance of existing externally validated prediction models for pre-eclampsia (PE) (specifically, any-onset, early-onset, late-onset and preterm PE). METHODS: A systematic search was conducted in five databases (MEDLINE, EMBASE, Emcare, CINAHL and Maternity & Infant Care Database) and using Google Scholar/reference search to identify studies based on the Population, Index prediction model, Comparator, Outcome, Timing and Setting (PICOTS) approach until 20 May 2023. We extracted data using the CHARMS checklist and appraised the risk of bias using the PROBAST tool. A meta-analysis of discrimination and calibration performance was conducted when appropriate. RESULTS: Twenty-three studies reported 52 externally validated prediction models for PE (one preterm, 20 any-onset, 17 early-onset and 14 late-onset PE models). No model had the same set of predictors. Fifteen any-onset PE models were validated externally once, two were validated twice and three were validated three times, while the Fetal Medicine Foundation (FMF) competing-risks model for preterm PE prediction was validated widely in 16 different settings. The most common predictors were maternal characteristics (prepregnancy body mass index, prior PE, family history of PE, chronic medical conditions and ethnicity) and biomarkers (uterine artery pulsatility index and pregnancy-associated plasma protein-A). The FMF model for preterm PE (triple test plus maternal factors) had the best performance, with a pooled area under the receiver-operating-characteristics curve (AUC) of 0.90 (95% prediction interval (PI), 0.76-0.96), and was well calibrated. The other models generally had poor-to-good discrimination performance (median AUC, 0.66 (range, 0.53-0.77)) and were overfitted on external validation. Apart from the FMF model, only two models that were validated multiple times for any-onset PE prediction, which were based on maternal characteristics only, produced reasonable pooled AUCs of 0.71 (95% PI, 0.66-0.76) and 0.73 (95% PI, 0.55-0.86). CONCLUSIONS: Existing externally validated prediction models for any-, early- and late-onset PE have limited discrimination and calibration performance, and include inconsistent input variables. The triple-test FMF model had outstanding discrimination performance in predicting preterm PE in numerous settings, but the inclusion of specialized biomarkers may limit feasibility and implementation outside of high-resource settings. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Tiruneh SA, Vu CT, Moran LJ, et al. Externally validated prediction models for pre-eclampsia: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2024. PMID: 37724649. doi:10.1002/uog.27490

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。